Ghent University Academic Bibliography

Advanced

Treatment of active spondyloarthropathy with infliximab, the chimeric monoclonal antibody to tumour necrosis factor alpha.

Filip Van Den Bosch, Dominique Baeten UGent, Elli Kruithof, Filip De Keyser UGent, Herman Mielants and Eric Veys (2001) ANNALS OF THE RHEUMATIC DISEASES. 60.
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (original)
publication status
published
subject
journal title
ANNALS OF THE RHEUMATIC DISEASES
Ann. Rheum. Dis.
volume
60
pages
III33-III36 Suppl. 3 pages
Web of Science type
Article
Web of Science id
000171874400007
JCR category
RHEUMATOLOGY
JCR impact factor
3.188 (2001)
JCR rank
2/21 (2001)
JCR quartile
1 (2001)
ISSN
0003-4967
language
English
UGent publication?
yes
classification
A1
id
169945
handle
http://hdl.handle.net/1854/LU-169945
date created
2004-01-14 13:40:00
date last changed
2016-12-19 15:37:55
@article{169945,
  author       = {Van Den Bosch, Filip and Baeten, Dominique and Kruithof, Elli and De Keyser, Filip and Mielants, Herman and Veys, Eric},
  issn         = {0003-4967},
  journal      = {ANNALS OF THE RHEUMATIC DISEASES},
  language     = {eng},
  pages        = {III33-III36 Suppl. 3},
  title        = {Treatment of active spondyloarthropathy with infliximab, the chimeric monoclonal antibody to tumour necrosis factor alpha.},
  volume       = {60},
  year         = {2001},
}

Chicago
Van Den Bosch, Filip, Dominique Baeten, Elli Kruithof, Filip De Keyser, Herman Mielants, and Eric Veys. 2001. “Treatment of Active Spondyloarthropathy with Infliximab, the Chimeric Monoclonal Antibody to Tumour Necrosis Factor Alpha.” Annals of the Rheumatic Diseases 60: 33.
APA
Van Den Bosch, F., Baeten, D., Kruithof, E., De Keyser, F., Mielants, H., & Veys, E. (2001). Treatment of active spondyloarthropathy with infliximab, the chimeric monoclonal antibody to tumour necrosis factor alpha. ANNALS OF THE RHEUMATIC DISEASES, 60, 33.
Vancouver
1.
Van Den Bosch F, Baeten D, Kruithof E, De Keyser F, Mielants H, Veys E. Treatment of active spondyloarthropathy with infliximab, the chimeric monoclonal antibody to tumour necrosis factor alpha. ANNALS OF THE RHEUMATIC DISEASES. 2001;60:33.
MLA
Van Den Bosch, Filip, Dominique Baeten, Elli Kruithof, et al. “Treatment of Active Spondyloarthropathy with Infliximab, the Chimeric Monoclonal Antibody to Tumour Necrosis Factor Alpha.” ANNALS OF THE RHEUMATIC DISEASES 60 (2001): 33. Print.